CLCD Insider Trading - CoLucid Pharmaceuticals, Inc.

Innsideraksjer

3 196 211 shares

Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Se høyest rangerte aksjer

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Se høyest rangerte aksjer

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

N/A

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

N/A

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

CoLucid Pharmaceuticals, Inc. insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider	Gjennomsnittlig fortjeneste (%)	Aksjer eid	Splitt justert

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i CLCD / CoLucid Pharmaceuticals, Inc.. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til maks
2016-09-09	Novo A/S	100 000	20,0000	100 000	20,0000	2 000 000	174
2015-08-25	Mathers Thomas P.	7 500	7,1033	7 500	7,1033	53 275
2015-05-11	Marengere Luc	500 000	10,0000	500 000	10,0000	5 000 000
2015-05-11	Novo A/S	1 300 000	10,0000	1 300 000	10,0000	13 000 000
2015-05-11	PAPPAS ARTHUR M	282 440	10,0000	282 440	10,0000	2 824 400
2015-05-11	PAPPAS ARTHUR M	17 560	10,0000	17 560	10,0000	175 600

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

CLCD / CoLucid Pharmaceuticals, Inc. Insider Trades

Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i CLCD / CoLucid Pharmaceuticals, Inc.. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til min
2017-01-05	Mathers Thomas P.	500	35,6000	500	35,6000	17 800	56
2017-01-05	Mathers Thomas P.	200	34,8625	200	34,8625	6 972
2017-01-05	Mathers Thomas P.	802	34,2462	802	34,2462	27 465
2016-12-05	Mathers Thomas P.	1 502	38,7500	1 502	38,7500	58 202
2016-11-07	Mathers Thomas P.	1 502	28,5732	1 502	28,5732	42 917
2016-10-05	Mathers Thomas P.	1 502	37,0800	1 502	37,0800	55 694
2016-09-07	Mathers Thomas P.	663	20,5555	663	20,5555	13 628
2016-09-07	Mathers Thomas P.	442	23,4267	442	23,4267	10 355
2016-09-07	Mathers Thomas P.	2 633	22,6164	2 633	22,6164	59 549

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil dato	Handels dato	Skjema	Innsider	Ticker	Verdipapirnavn	Kode	Direkte	Utøvelses pris	Enhets pris	Enheter endret	Verdi endret (1K)	Gjenværende Opsjoner	Gjenværende Aksjer
2017-03-01	2017-03-01	4	LILLY ELI & CO	CLCD	Common Stock, par value $0.001	J - Other	D		46,5000	19 285 108	896 758		100
2017-03-01	2017-03-01	4	PAPPAS ARTHUR M	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,24	40,2600	−8 897	−358	0
2017-03-01	2017-03-01	4	PAPPAS ARTHUR M	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	10,00	36,5000	−5 954	−217	0
2017-03-01	2017-03-01	4	PAPPAS ARTHUR M By Pappas Capital, LLC	CLCD	Common Stock	U - Other	I		46,5000	−5 528	−257		0
2017-03-01	2017-03-01	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Common Stock	U - Other	I		46,5000	−116 317	−5 409		0
2017-03-01	2017-03-01	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock	U - Other	I		46,5000	−1 871 049	−87 004		0
2017-03-01	2017-03-01	4	Skwierczynski Raymond	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	6,75	39,7500	−15 000	−596	0
2017-03-01	2017-03-01	4	Skwierczynski Raymond	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	5,69	40,8100	−90 000	−3 673	0
2017-03-01	2017-03-01	4	Skwierczynski Raymond	CLCD	Common Stock	U - Other	D		46,5000	−3 615	−168		0
2017-03-01	2017-03-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	36,20	10,3000	−453	−5	0
2017-03-01	2017-03-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	9,62	36,8800	−1 630	−60	0
2017-03-01	2017-03-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,24	40,2600	−8 897	−358	0
2017-03-01	2017-03-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	8,50	38,0000	−997	−38	0
2017-03-01	2017-03-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	8,60	37,9000	−6 577	−249	0
2017-03-01	2017-03-01	4	Mathers Thomas P.	CLCD	Restricted Stock Units	D - Sale to Issuer	D		46,5000	−105 147	−4 889	0
2017-03-01	2017-03-01	4	Mathers Thomas P.	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	6,75	39,7500	−83 000	−3 299	0
2017-03-01	2017-03-01	4	Mathers Thomas P.	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	10,00	36,5000	−360 508	−13 159	0
2017-03-01	2017-03-01	4	Mathers Thomas P.	CLCD	Common Stock	D - Sale to Issuer	D		46,5000	−83 000	−3 860		0
2017-03-01	2017-03-01	4	Mathers Thomas P.	CLCD	Common Stock	U - Other	D		46,5000	−173 519	−8 069		0
2017-03-01	2017-03-01	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	36,20	10,3000	−658	−7	0
2017-03-01	2017-03-01	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,24	40,2600	−8 897	−358	0
2017-03-01	2017-03-01	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,54	39,9600	−1 420	−57	0
2017-03-01	2017-03-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	36,20	10,3000	−658	−7	0
2017-03-01	2017-03-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	9,62	36,8800	−2 371	−87	0
2017-03-01	2017-03-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,24	40,2600	−8 897	−358	0
2017-03-01	2017-03-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	8,50	38,0000	−1 449	−55	0
2017-03-01	2017-03-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	10,00	36,5000	−5 954	−217	0
2017-03-01	2017-03-01	4	Marengere Luc By TVM Life Science Ventures VII L.P.	CLCD	Common Stock	U - Other	I		46,5000	−1 545 386	−71 860		0
2017-03-01	2017-03-01	4	CORRIGAN MARK	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,24	40,2600	−8 897	−358	0
2017-03-01	2017-03-01	4	CORRIGAN MARK	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	3,79	42,7100	−8 114	−347	0
2017-03-01	2017-03-01	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	6,75	39,7500	−37 500	−1 491	0
2017-03-01	2017-03-01	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	7,56	38,9400	−30 000	−1 168	0
2017-03-01	2017-03-01	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	D - Sale to Issuer	D	10,00	36,5000	−180 254	−6 579	0
2017-03-01	2017-03-01	4	Dallas Matthew D	CLCD	Common Stock	D - Sale to Issuer	D		46,5000	−37 500	−1 744		0
2017-03-01	2017-03-01	4	Dallas Matthew D	CLCD	Common Stock	U - Other	D		46,5000	−2 708	−126		0
2017-03-01	2017-03-01	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	6,75	39,7500	−26 594	−1 057	0
2017-03-01	2017-03-01	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	7,56	38,9400	−5 741	−224	0
2017-03-01	2017-03-01	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	D - Sale to Issuer	D	10,00	36,5000	−46 966	−1 714	0
2017-03-01	2017-03-01	4	Kuca Bernice	CLCD	Employee Stock Option (right to buy)	D - Sale to Issuer	D	6,75	39,7500	−37 500	−1 491	0
2017-03-01	2017-03-01	4	Kuca Bernice	CLCD	Employee Stock Option (right to buy)	D - Sale to Issuer	D	10,00	36,5000	−270 381	−9 869	0
2017-03-01	2017-03-01	4	Kuca Bernice	CLCD	Common Stock	D - Sale to Issuer	D		46,5000	−37 500	−1 744		0
2017-03-01	2017-03-01	4	Kuca Bernice	CLCD	Common Stock	U - Other	D		46,5000	−2 729	−127		0
2017-01-27		3	ProCar Acquisition Corp	CLCD	Common stock		D						109 366
2017-01-27		3	ProCar Acquisition Corp	CLCD	Common stock		D						109 366
2017-01-27		3	ProCar Acquisition Corp	CLCD	Common stock		D						109 366
2017-01-05	2017-01-05	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	10,00		−1 677		46 966
2017-01-05	2017-01-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		35,6083	−600	−21		0
2017-01-05	2017-01-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		34,4000	−600	−21		600
2017-01-05	2017-01-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		33,5548	−477	−16		1 200
2017-01-05	2017-01-05	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		10,0000	1 677	17		1 677
2017-01-05	2017-01-04	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	7,56		−185		5 741
2017-01-05	2017-01-04	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		36,4000	−185	−7		0
2017-01-05	2017-01-04	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		7,5600	185	1		185
2017-01-05	2017-01-03	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	6,75		−718		26 594
2017-01-05	2017-01-03	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		36,2500	−718	−26		0
2017-01-05	2017-01-03	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		6,7500	718	5		718
2017-01-05	2017-01-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 755		105 147
2017-01-05	2017-01-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		35,6000	−500	−18		256 519
2017-01-05	2017-01-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		34,8625	−200	−7		257 019
2017-01-05	2017-01-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		34,2462	−802	−27		257 219
2017-01-05	2017-01-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 755			258 021
2017-01-04	2017-01-03	4	White Marvin L	CLCD	Stock Option (Right to Buy)	A - Award	D	36,20	30,3500	453	14	453
2017-01-04	2017-01-03	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	A - Award	D	36,20	30,4000	658	20	658
2017-01-04	2017-01-03	4	Dallas Matthew D	CLCD	Common Stock	S - Sale	D		36,2500	−1 473	−53		40 128
2017-01-04	2017-01-03	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	A - Award	D	36,20	30,4000	658	20	658
2017-01-04	2017-01-03	4	Kuca Bernice	CLCD	Common Stock	S - Sale	D		36,2500	−772	−28		40 086
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	10,00		−1 678		48 643
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	7,56		−186		5 926
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		38,7500	−1 678	−65		0
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		10,0000	1 678	17		1 678
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		38,7500	−186	−7		0
2016-12-05	2016-12-05	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		7,5600	186	1		186
2016-12-05	2016-12-01	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	6,75		−719		27 312
2016-12-05	2016-12-01	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		35,2191	−719	−25		0
2016-12-05	2016-12-01	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		6,7500	719	5		719
2016-12-05	2016-12-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 756		108 902
2016-12-05	2016-12-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		38,7500	−1 502	−58		254 266
2016-12-05	2016-12-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 756			255 768
2016-12-01	2016-12-01	4	Dallas Matthew D	CLCD	Common Stock	S - Sale	D		35,1671	−1 473	−52		41 601
2016-12-01	2016-12-01	4	Kuca Bernice	CLCD	Common Stock	S - Sale	D		35,2202	−772	−27		40 858
2016-11-07	2016-11-07	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	10,00		−1 677		50 321
2016-11-07	2016-11-07	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		28,5212	−1 677	−48		0
2016-11-07	2016-11-07	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		10,0000	1 677	17		1 677
2016-11-07	2016-11-04	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	7,56		−185		6 112
2016-11-07	2016-11-04	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		28,9500	−185	−5		0
2016-11-07	2016-11-04	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		7,5600	185	1		185
2016-11-07	2016-11-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		28,5732	−1 502	−43		248 920
2016-11-07	2016-11-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 755		112 658
2016-11-07	2016-11-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 755			250 422
2016-11-01	2016-11-01	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	6,75		−719		28 031
2016-11-01	2016-11-01	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		30,0000	−719	−22		0
2016-11-01	2016-11-01	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		6,7500	719	5		719
2016-10-05	2016-10-05	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	10,00		−1 677		51 998
2016-10-05	2016-10-05	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		37,0800	−1 677	−62		0
2016-10-05	2016-10-05	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		10,0000	1 677	17		1 677
2016-10-05	2016-10-04	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	7,56		−185		6 297
2016-10-05	2016-10-04	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		36,4100	−185	−7		0
2016-10-05	2016-10-04	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		7,5600	185	1		185
2016-10-05	2016-10-03	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	6,75		−719		28 750
2016-10-05	2016-10-03	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		37,7400	−719	−27		0
2016-10-05	2016-10-03	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		6,7500	719	5		719
2016-10-05	2016-10-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 755		116 413
2016-10-05	2016-10-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		37,0800	−1 502	−56		246 667
2016-10-05	2016-10-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 755			248 169
2016-09-16	2016-09-14	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		23,7800	−300	−7		244 414
2016-09-16	2016-09-14	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		23,3004	−5 700	−133		244 714
2016-09-13	2016-09-09	4	Domain Partners VI, L.P.	CLCD	Common Stock	J - Other	D			−1 943 109			0
2016-09-13	2016-09-09	4	Novo A/S	CLCD	COMMON STOCK	P - Purchase	D		20,0000	100 000	2 000		3 156 563
2016-09-07	2016-09-06	4	Hogan Linda C. By LLH Associates, LLC	CLCD	Stock Option (Right to Buy)	M - Exercise	I	5,09		−896		0
2016-09-07	2016-09-06	4	Hogan Linda C. By LLH Associates, LLC	CLCD	Stock Option (Right to Buy)	M - Exercise	I	5,09		−2 839		0
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	6,75		−5 031		29 469
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	7,56		−3 518		6 482
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	M - Exercise	D	10,00		−36 452		53 675
2016-09-07	2016-09-06	4	Hogan Linda C. By LLH Associates, LLC	CLCD	Common Stock	S - Sale	I		19,5000	−3 735	−73		0
2016-09-07	2016-09-06	4	Hogan Linda C. By LLH Associates, LLC	CLCD	Common Stock	M - Exercise	I		5,0900	896	5		3 735
2016-09-07	2016-09-06	4	Hogan Linda C. By LLH Associates, LLC	CLCD	Common Stock	M - Exercise	I		5,0900	2 839	14		2 839
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		20,0011	−31 420	−628		0
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		20,0000	−5 032	−101		31 420
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	S - Sale	D		19,5000	−8 549	−167		36 452
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		6,7500	5 031	34		45 001
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		7,5600	3 518	27		39 970
2016-09-07	2016-09-06	4	Hogan Linda C.	CLCD	Common Stock	M - Exercise	D		10,0000	36 452	365		36 452
2016-09-07	2016-09-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		24,3967	−300	−7		250 414
2016-09-07	2016-09-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		23,4267	−442	−10		250 714
2016-09-07	2016-09-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		22,6164	−2 633	−60		251 156
2016-09-07	2016-09-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		21,9045	−962	−21		253 789
2016-09-07	2016-09-07	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		20,5555	−663	−14		254 751
2016-09-07	2016-09-06	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		19,5000	−1 502	−29		255 414
2016-09-07	2016-09-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 756		120 168
2016-09-07	2016-09-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 756			256 916
2016-08-31	2016-08-31	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		10,8600	−150	−2		47
2016-08-19	2016-08-19	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		8,4100	−508	−4		197
2016-08-10	2016-08-10	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		8,3000	−508	−4		705
2016-08-05	2016-08-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 755		123 924
2016-08-05	2016-08-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		8,3100	−1 502	−12		253 160
2016-08-05	2016-08-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 755			254 662
2016-08-03	2016-08-03	4	Domain Partners VI, L.P.	CLCD	Common Stock	S - Sale	D		8,1500	−81 094	−661		1 943 109
2016-08-03	2016-08-02	4	Domain Partners VI, L.P.	CLCD	Common Stock	S - Sale	D		8,7100	−19 718	−172		2 024 203
2016-08-03	2016-08-01	4	Domain Partners VI, L.P.	CLCD	Common Stock	S - Sale	D		8,8200	−52 216	−461		2 043 921
2016-08-03	2016-08-03	4	DP VI Associates, L.P.	CLCD	Common Stock	S - Sale	D		8,1500	−129	−1		3 039
2016-08-03	2016-08-02	4	DP VI Associates, L.P.	CLCD	Common Stock	S - Sale	D		8,7100	−32	−0		3 168
2016-08-03	2016-08-01	4	DP VI Associates, L.P.	CLCD	Common Stock	S - Sale	D		8,8200	−84	−1		3 200
2016-07-29	2016-07-29	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		9,0850	−508	−5		1 213
2016-07-20	2016-07-20	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		8,9700	−508	−5		1 721
2016-07-12	2016-07-11	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		9,1000	−508	−5		2 229
2016-07-05	2016-07-01	4	White Marvin L	CLCD	Stock Option (Right to Buy)	A - Award	D	9,62	8,4400	1 630	14	1 630
2016-07-05	2016-07-01	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	A - Award	D	9,62	8,4400	2 371	20	2 371
2016-07-05	2016-07-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 755		127 679
2016-07-05	2016-07-05	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		9,7300	−1 502	−15		250 907
2016-07-05	2016-07-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 755			252 409
2016-06-30	2016-06-30	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		7,0110	−516	−4		2 737
2016-06-22	2016-06-20	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		7,0000	−500	−4		3 253
2016-06-22	2016-06-10	4	Skwierczynski Raymond	CLCD	Common Stock	S - Sale	D		6,5984	−508	−3		3 753
2016-06-07	2016-06-06	4	Mathers Thomas P.	CLCD	Common Stock	S - Sale	D		7,2463	−1 502	−11		248 654
2016-06-07	2016-06-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−3 756		131 434
2016-06-07	2016-06-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			3 756			250 156
2016-05-12	2016-05-10	4	CORRIGAN MARK	CLCD	Stock Option (Right to Buy)	A - Award	D	6,24		8 897		8 897
2016-05-12	2016-05-10	4	PAPPAS ARTHUR M	CLCD	Stock Option (Right to Buy)	A - Award	D	6,24		8 897		8 897
2016-05-12	2016-05-10	4	White Marvin L	CLCD	Stock Option (Right to Buy)	A - Award	D	6,24		8 897		8 897
2016-05-12	2016-05-10	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	A - Award	D	6,24		8 897		8 897
2016-05-12	2016-05-10	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	A - Award	D	6,24		8 897		8 897
2016-05-09	2016-05-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−45 064		135 190
2016-05-09	2016-05-05	4	Mathers Thomas P.	CLCD	Common Stock	F - Taxes	D		6,4900	−14 624	−95		241 400
2016-05-09	2016-05-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			45 064			256 024
2016-05-02	2016-04-28	4	DP VI Associates, L.P.	CLCD	Common Stock	S - Sale	D		6,9600	−235	−2		3 284
2016-05-02	2016-04-28	4	Domain Partners VI, L.P.	CLCD	Common Stock	S - Sale	D		6,9600	−149 765	−1 042		2 096 137
2016-03-15	2016-03-11	4	Lawton Alison Frances	CLCD	Stock Option (Right to Buy)	A - Award	D	6,54		1 420		1 420
2016-03-07	2016-03-04	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	6,75		37 500		37 500
2016-03-07	2016-03-04	4	Dallas Matthew D	CLCD	Common Stock	A - Award	D			37 500			37 500
2016-03-07	2016-03-04	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	A - Award	D	6,75		34 500		34 500
2016-03-07	2016-03-04	4	Kuca Bernice	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	6,75		37 500		37 500
2016-03-07	2016-03-04	4	Kuca Bernice	CLCD	Common Stock	A - Award	D			37 500			37 500
2016-03-07	2016-03-04	4	Mathers Thomas P.	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	6,75		83 000		83 000
2016-03-07	2016-03-04	4	Mathers Thomas P.	CLCD	Common Stock	A - Award	D			83 000			210 960
2016-03-07	2016-03-04	4	Skwierczynski Raymond	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	6,75		15 000		15 000
2016-01-06	2016-01-04	4	White Marvin L	CLCD	Stock Option (Right to Buy)	A - Award	D	8,50	6,9000	997	7	997
2016-01-06	2016-01-04	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	A - Award	D	8,50	6,9000	1 449	10	1 449
2015-12-02	2015-11-30	4	Skwierczynski Raymond	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	5,69		90 000		90 000
2015-11-06	2015-11-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	M - Exercise	D			−180 254		180 254
2015-11-06	2015-11-05	4	Mathers Thomas P.	CLCD	Common Stock	F - Taxes	D		4,5800	−59 794	−274		127 960
2015-11-06	2015-11-05	4	Mathers Thomas P.	CLCD	Common Stock	M - Exercise	D			180 254			187 754
2015-10-29	2015-10-27	4	CORRIGAN MARK	CLCD	Stock Option (Right to Buy)	A - Award	D	3,79		8 114		8 114
2015-08-25	2015-08-25	4	Mathers Thomas P.	CLCD	Common Stock	P - Purchase	D		7,1033	7 500	53		7 500
2015-08-06	2015-08-04	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	A - Award	D	7,56		10 000		10 000
2015-08-06	2015-08-04	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	7,56		30 000		30 000
2015-07-13	2015-07-09	4	White Marvin L	CLCD	Stock Option (Right to Buy)	A - Award	D	8,60		6 577		6 577
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Employee Stock Option (Right to Buy)	M - Exercise	D	5,09		−3 690		0
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Employee Stock Option (Right to Buy)	M - Exercise	D	5,09		−5 541		0
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Employee Stock Option (Right to Buy)	M - Exercise	D	4,07		−2 457		0
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Employee Stock Option (Right to Buy)	M - Exercise	D	4,07		−2 457		0
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Common Stock	M - Exercise	D		5,0900	3 690	19		14 145
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Common Stock	M - Exercise	D		5,0900	5 541	28		10 455
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Common Stock	M - Exercise	D		4,0700	2 457	10		4 914
2015-05-13	2015-05-13	4	Rupniak Nadia	CLCD	Common Stock	M - Exercise	D		4,0700	2 457	10		4 914
2015-05-12	2015-05-11	4	Novo A/S	CLCD	SERIES C PREFERRED STOCK	C - Conversion	D			−1 756 563		0
2015-05-12	2015-05-11	4	Novo A/S	CLCD	COMMON STOCK	P - Purchase	D		10,0000	1 300 000	13 000		3 056 563
2015-05-12	2015-05-11	4	Novo A/S	CLCD	COMMON STOCK	C - Conversion	D			1 756 563			1 756 563
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series C Convertible Preferred Stock	C - Conversion	I			−20 808		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series C Convertible Preferred Stock	C - Conversion	I			−334 722		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series B Convertible Preferred Stock	C - Conversion	I			−41 996		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series B Convertible Preferred Stock	C - Conversion	I			−675 588		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series A Convertible Preferred Stock	C - Conversion	I			−35 953		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series A Convertible Preferred Stock	C - Conversion	I			−578 297		0
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Common Stock	P - Purchase	I		10,0000	17 560	176		116 317
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock	P - Purchase	I		10,0000	282 440	2 824		1 871 049
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Common Stock	C - Conversion	I			98 757			98 757
2015-05-12	2015-05-11	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock	C - Conversion	I			1 588 607			1 588 609
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Offshore Investments III, LP	CLCD	Series C Convertible Preferred Stock	C - Conversion	I			−5 353		0
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Investments III, LP	CLCD	Series C Convertible Preferred Stock	C - Conversion	I			−320 295		0
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Offshore Investments III, LP	CLCD	Series B Convertible Preferred Stock	C - Conversion	I			−20 050		0
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Investments III, LP	CLCD	Series B Convertible Preferred Stock	C - Conversion	I			−1 199 841		0
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Offshore Investments III, LP	CLCD	Common Stock	C - Conversion	I			25 403			25 403
2015-05-12	2015-05-11	4	Markham Richard J By Care Capital Investments III, LP	CLCD	Common Stock	C - Conversion	I			1 520 136			1 520 136
2015-05-12	2015-05-11	4	Marengere Luc By TVM Life Science Ventures VII L.P.	CLCD	Series C Convertible Preferred Stock	C - Conversion	I			−995 386		0
2015-05-12	2015-05-11	4	Marengere Luc By TVM Life Science Ventures VII L.P.	CLCD	Common Stock	P - Purchase	I		10,0000	500 000	5 000		1 495 386
2015-05-12	2015-05-11	4	Marengere Luc By TVM Life Science Ventures VII L.P.	CLCD	Common Stock	C - Conversion	I			995 386			995 386
2015-05-11	2015-05-11	4	Domain Partners VI, L.P.	CLCD	Series C Preferred Stock	C - Conversion	D			−464 756		0
2015-05-11	2015-05-11	4	Domain Partners VI, L.P.	CLCD	Series B Preferred Stock	C - Conversion	D			−939 289		0
2015-05-11	2015-05-11	4	Domain Partners VI, L.P.	CLCD	Series A Preferred Stock	C - Conversion	D			−798 188		0
2015-05-11	2015-05-11	4	Domain Partners VI, L.P.	CLCD	Common Stock	C - Conversion	D			2 202 233			2 245 902
2015-05-11	2015-05-11	4	DP VI Associates, L.P.	CLCD	Series B Preferred Stock	C - Conversion	D			−1 565		0
2015-05-11	2015-05-11	4	DP VI Associates, L.P.	CLCD	Series A Preferred Stock	C - Conversion	D			−1 954		0
2015-05-11	2015-05-11	4	DP VI Associates, L.P.	CLCD	Common Stock	C - Conversion	D			3 519			3 519
2015-05-07	2015-05-05	4	TREU JESSE I	CLCD	Stock Option (Right to Buy)	A - Award	D	10,00		5 954		5 954
2015-05-07	2015-05-05	4	PAPPAS ARTHUR M	CLCD	Stock Option (Right to Buy)	A - Award	D	10,00		5 954		5 954
2015-05-07	2015-03-23	4	PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC	CLCD	Stock Option (Right to Buy)	M - Exercise	I	4,07		−5 528		0
2015-05-07	2015-03-23	4	PAPPAS ARTHUR M By A.M. Pappas & Associates, LLC	CLCD	Common Stock	M - Exercise	I		4,0700	5 528	22		5 528
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series C Convertible Preferred Stock	P - Purchase	I			20 808		20 808
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series C Convertible Preferred Stock	P - Purchase	I			334 722		334 722
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series B Convertible Preferred Stock	P - Purchase	I			33 597		33 597
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series B Convertible Preferred Stock	P - Purchase	I			540 470		540 470
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By PV III CEO Fund, L.P.	CLCD	Series A Convertible Preferred Stock	P - Purchase	I			28 763		28 763
2015-05-07	2015-01-12	4	PAPPAS ARTHUR M By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Series A Convertible Preferred Stock	P - Purchase	I			462 637		462 637
2015-05-07	2015-05-05	4	Markham Richard J	CLCD	Stock Option (Right to Buy)	A - Award	D	10,00		5 954		5 954
2015-05-07	2015-01-12	4	Markham Richard J By Care Capital Offshore Investments III, LP	CLCD	Series C Convertible Preferred Stock	P - Purchase	I			5 353		5 353
2015-05-07	2015-01-12	4	Markham Richard J By Care Capital Investments III, LP	CLCD	Series C Convertible Preferred Stock	P - Purchase	I			320 295		320 295
2015-05-07	2015-01-12	4	Markham Richard J By Care Capital Offshore Investments III, LP	CLCD	Series B Convertible Preferred Stock	P - Purchase	I			16 041		16 041
2015-05-07	2015-01-12	4	Markham Richard J By Care Capital Investments III, LP	CLCD	Series B Convertible Preferred Stock	P - Purchase	I			959 872		959 872
2015-05-07	2015-05-05	4	Dallas Matthew D	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	10,00		180 254		180 254
2015-05-07	2015-05-05	4	Hogan Linda C.	CLCD	Stock Option (Right to Buy)	A - Award	D	10,00		90 127		90 127
2015-05-07	2015-05-05	4	Rupniak Nadia	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	10,00		135 190		135 190
2015-05-07	2015-05-05	4	Kuca Bernice	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	10,00		270 381		270 381
2015-05-07	2015-05-05	4	Mathers Thomas P.	CLCD	Employee Stock Option (Right to Buy)	A - Award	D	10,00		360 508		360 508
2015-05-07	2015-05-05	4	Mathers Thomas P.	CLCD	Restricted Stock Units	A - Award	D			360 508		360 508
2015-05-07	2015-05-05	4	Marengere Luc	CLCD	Stock Option (Right to Buy)	A - Award	D	10,00		5 954		5 954
2015-05-07	2015-01-12	4	Marengere Luc By TVM Life Science Ventures VII L.P.	CLCD	Series C Convertible Preferred Stock	P - Purchase	I			995 386		995 386
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	VITULLO NICOLE	CLCD	Common Stock		D						87 338
2015-05-05		3	PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC	CLCD	Common Stock		I						11 058
2015-05-05		3	PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock		I						5 532
2015-05-05		3	PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock		I						5 532
2015-05-05		3	PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC	CLCD	Common Stock		I						11 058
2015-05-05		3	PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock		I						5 532
2015-05-05		3	PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC	CLCD	Common Stock		I						11 058
2015-05-05		3	PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC	CLCD	Common Stock		I						11 058
2015-05-05		3	PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock		I						5 532
2015-05-05		3	PAPPAS CAPITAL, LLC By A.M. Pappas & Associates, LLC	CLCD	Common Stock		I						11 058
2015-05-05		3	PAPPAS CAPITAL, LLC By A. M. Pappas Life Science Ventures III, L.P.	CLCD	Common Stock		I						5 532

Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.

Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)

Konvertering av derivat

Salg eller overføring av verdipapirer tilbake til selskapet

Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet

Gave av verdipapirer fra eller til insidere

Aksjebytting og lignende sikringsavtaler

Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)

En transaksjon frivilig rapportert på Skjema 4

Annet (med en fotnote som beskriver transaksjonen)

CLCD / CoLucid Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5